"The French National Institute of Cancer has introduced a competitive site endorsement policy. This policy aims to provide new operational conditions for translational research in oncology that will optimise and accelerate the production of new knowledge and promote its dissemination and application in the treatment of cancers.
As such the creation of integrated cancer research sites (SIRICs) should lead to significant changes in the conduction of multidisciplinary and integrated research” Source: Institut National du Cancer.
The funding of SiRICs is provided jointly by the National Cancer Institute (INCa), the health ministry (DGOS) and The French National Institute of Health and Medical Research (Inserm) on behalf of French National Alliance for Life Sciences and Health (Aviesan) for 5 years.
Built on our institutional strength and in concordance with SiRIC’s goals, the funding linked to the SiRIC label allows us to:
- Develop 8 integrated research programs. The projects, which correspond with the 8 SiRIC-Curie themes, are funded by multiple sources (donations, project funding, industrial partnerships or institutional funds). SiRIC-Curie brings structural support in the form of key positions or equipment.
- Identify and put in place new translational research teams
- Support emerging translational research teams via the funding of key posts
- Offer support in the form of « protected medical time » allowing clinicians to devote a part of their time to research
- Funding of thesis’ / masters and participation in international courses in order to train clinician-researchers
- Put in place cutting edge and innovative infrastructures (platforms, data management, think tanks …)
- Support the emergence of translational research projects with internal calls for projects
- Spread knowledge via the organisation of scientific events and training initiatives